C148-0213 Screening compound: ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

C148-0213 Screening compound: ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate
C148-0213 Screening compound: ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C148-0213
ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C148-0213

Molecular Formula

C27H32ClN5O4S (C27 H32 ClN5 O4 S)

Compound Name

ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

IUPAC name

ethyl 4-(4-{[(4-chlorophenyl)carbamoyl]methyl}-3-[2-(4-methylpiperazin-1-yl)ethyl]-5-oxo-2-sulfanylideneimidazolidin-1-yl)benzoate

SMILES

CCOC(c(cc1)ccc1N(C(C(CC(Nc(cc1)ccc1Cl)=O)N1CCN2CCN(C)CC2)=O)C1=S)=O

InChI

InChI=1S/C27H32ClN5O4S/c1-3-37-26(36)19-4-10-22(11-5-19)33-25(35)23(18-24(34)29-21-8-6-20(28)7-9-21)32(27(33)38)17-16-31-14-12-30(2)13-15-31/h4-11,23H,3,12-18H2,1-2H3,(H,29,34)/t23-/m0/s1

InChI Key

FMAFSMPZQKAELW-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD14722480

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

558.1

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.906

Distribution Coefficient, logD

1.661

Water Solubility, LogSw

-3.71

Polar Surface Area

69.588

Acid Dissociation Constant (pKa)

10.39

Base Dissociation Constant (pKb)

8.62

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

C148-0213 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with C148-0213 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C148-0213?
Check Price and Availability of C148-0213, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C148-0213 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C148-0213
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C148-0213
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C148-0213 available by request